Provided by Tiger Fintech (Singapore) Pte. Ltd.

Simulations Plus

34.35
-0.7100-2.03%
Post-market: 34.01-0.3400-0.99%18:39 EDT
Volume:281.63K
Turnover:9.74M
Market Cap:690.81M
PE:95.39
High:35.02
Open:34.88
Low:34.00
Close:35.06
Loading ...

Craig-Hallum Issues a Buy Rating on Simulations Plus (SLP)

TIPRANKS
·
23 Dec 2024

BRIEF-Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings And Conference Call Date

Reuters
·
18 Dec 2024

Press Release: Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

Dow Jones
·
18 Dec 2024

Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date

THOMSON REUTERS
·
18 Dec 2024

US Growth Stocks With High Insider Ownership For December 2024

Simply Wall St.
·
13 Dec 2024

Simulations Plus, Inc.'s (NASDAQ:SLP) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Simply Wall St.
·
05 Dec 2024

Wall Street Analysts Predict a 56.99% Upside in Simulations Plus (SLP): Here's What You Should Know

Zacks
·
26 Nov 2024

Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar?

Zacks
·
22 Nov 2024

Simulations Plus to Participate in the BTIG Digital Health Forum

Business Wire
·
19 Nov 2024

Simulations Plus Initiated at Overweight by Stephens & Co.

Dow Jones
·
16 Nov 2024

Stephens Initiates Simulations Plus at Overweight With $39 Price Target

MT Newswires Live
·
15 Nov 2024

Simulations Plus Inc : Stephens Initiates Coverage With Overweight Rating; Target Price $39

THOMSON REUTERS
·
15 Nov 2024

US Growth Stocks With High Insider Ownership Seeing Up To 115% Earnings Growth

Simply Wall St.
·
14 Nov 2024

US Growth Stocks With High Insider Ownership Seeing Up To 115% Earnings Growth

Simply Wall St.
·
14 Nov 2024

FDA grants Simulations Plus to use PBPK to expand mechanistic modeling for LAI

TIPRANKS
·
13 Nov 2024

BRIEF-Simulations Plus And The University Of Connecticut Receive New FDA Grant To Expand Mechanistic Modeling Approaches For Long-Acting Injectables

Reuters
·
13 Nov 2024

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

THOMSON REUTERS
·
13 Nov 2024

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables

Business Wire
·
13 Nov 2024

Salesforce.com (CRM) Moves 6.1% Higher: Will This Strength Last?

Zacks
·
13 Nov 2024

How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52%

Zacks
·
08 Nov 2024